Navigation Links
Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem Cell Policy
Date:3/12/2009

destroy invading enemies. ESCs are so perceived by the human immune system and always will be.

Fourth, California, with $275 million of stem cell funding to give away last spring, could not find one embryonic scientist in the state who was worthy of two cents worth of funding.

Fifth, there are many ways of creating "embryonic-like" stem cells good for lab research, by using what The Institute heartily endorses, adult cells.

Sixth, economics: there is no way anyone can make money from the disaster known as embryonics. Just ask those who tried to cash in on the Geron hype a few weeks ago."

If a loved one suffers from something "incurable," check out our list of highly-honored doctors and the 100+ diseases they are treating in 2009, NOT 2025."

Mr. Margolis concluded: "For a full explanation of each of these six points, read "The Grim Fairy Tale" on our website.

About the Repair Stem Cell Institute (RSCI): The Repair Stem Cell Institute's mission is to educate and inform everyone about the rapid advances being made in Repair Stem Cell research, so all can intelligently exercise freedom of choice in medical care. Founded in 2008, RSCI is located in Bangkok, Thailand, and Dallas, Texas.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2228644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
2. Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
3. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
4. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
5. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
6. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Repair Stem Cell Institute Announces Science Advisory Board
10. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
11. Real-time observation of the DNA-repair mechanism
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4